Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
REVIEW ARTICLE  

 Article Access Statistics
    Viewed1512    
    Printed63    
    Emailed1    
    PDF Downloaded932    
    Comments [Add]    

Recommend this journal

Anaesthetic management of patients with congenital heart disease presenting for non-cardiac surgery.


Department of Anaesthesiology, University of Minnesota Medical School, Minneapolis, Minnesota

Correspondence Address:
R Mohindra
Department of Anaesthesiology, University of Minnesota Medical School, Minneapolis, Minnesota

Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 17890798

Rights and PermissionsRights and Permissions

Year : 2002  |  Volume : 5  |  Issue : 1  |  Page : 15-24

 

SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for

  Article in PDF (340 KB)
Email article
Print Article
Add to My List
The incidence of congenital heart disease is about one percent of all live births in the United States. Treatment is being performed at a younger age and these children are showing improved survival. It is not unusual for children with congenital heart disease to present for non-cardiac surgery. Their management depends on their age, type of lesion, extent of corrective procedure, the presence of complications and other congenital anomalies. Each patient needs a detailed pre-operative evaluation to understand the abnormal anatomy and physiology, and related anaesthetic implications. No anaesthetic agent is an absolute contraindication, although drugs beneficial for one lesion may be detrimental for another. Regional anaesthesia has also been safely used in children with congenital heart disease. However the anaesthesiologist must have a detailed understanding of the pathophysiology of the lesion and the pharmacology of drugs being used to be able to provide safe anaesthesia for children with congenital heart disease.






[PDF]*
 

 

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 REVIEW ARTICLE
 




Department of Anaesthesiology, University of Minnesota Medical School, Minneapolis, Minnesota

Correspondence Address:
R Mohindra
Department of Anaesthesiology, University of Minnesota Medical School, Minneapolis, Minnesota

Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 17890798

Rights and PermissionsRights and Permissions

The incidence of congenital heart disease is about one percent of all live births in the United States. Treatment is being performed at a younger age and these children are showing improved survival. It is not unusual for children with congenital heart disease to present for non-cardiac surgery. Their management depends on their age, type of lesion, extent of corrective procedure, the presence of complications and other congenital anomalies. Each patient needs a detailed pre-operative evaluation to understand the abnormal anatomy and physiology, and related anaesthetic implications. No anaesthetic agent is an absolute contraindication, although drugs beneficial for one lesion may be detrimental for another. Regional anaesthesia has also been safely used in children with congenital heart disease. However the anaesthesiologist must have a detailed understanding of the pathophysiology of the lesion and the pharmacology of drugs being used to be able to provide safe anaesthesia for children with congenital heart disease.






[PDF]*


        
Print this article     Email this article